Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase…

Overview of attention for article published in Journal of Clinical Oncology, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence…

This Reading Room is a collaboration between MedPage Today® and: About half of patients with platinum-sensitive relapsed…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.